Last update 23 Jan 2025

HMV-MAA x CD28

Basic Info

Related Targets
HMV-MAACD28

Related

1
Drugs associated with HMV-MAA x CD28
Anti-CD28/anti-HMV-MAA bispecific antibody(Eberhard Karls Universitat Tubingen)
Target
CD28 x HMV-MAA
Mechanism
CD28 modulators [+1]
Active Org.-
Originator Org.
Eberhard Karls Universität TübingenEberhard Karls Universität Tübingen
Active Indication-
Inactive Indication
Neoplasms
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with HMV-MAA x CD28
NCT00204594
/ CompletedPhase 1/2IIT
Local Treatment of Metastatic Melanoma With Autologous Lymphocytes and the Bispecific Antibody rM28
100 Clinical Results associated with HMV-MAA x CD28
Login to view more data
100 Translational Medicine associated with HMV-MAA x CD28
Login to view more data
0 Patents (Medical) associated with HMV-MAA x CD28
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free